Quasi-random interferometric optical fiber biosensor for label-free quantitative detection of CD44-expressing cancer cells

Marzhan Nurlankyzy, Kanagat Kantoreyeva, Aida Zhakypbekova, Zhannat Ashikbayeva, Damira A. Kanayeva, Carlos Marques, Santosh Kumar, Milan S Kovačević, Wilfried Blanc, Constantinos A. Valagiannopoulos

2 more authors

Aliya Bekmurzayeva, Daniele Tosi

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1016/j.biosx.2026.100805
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The use of whole cancer cells as a biomarker, as opposed to smaller analytes such as proteins, is essential for advancing diagnostic tools. In this work, a quasi-random interferometer-based optical fiber biosensor is proposed for the quantitative, label-free, and real-time detection of CD44-expressing cancer cells. The sensor is low-cost, easy to fabricate, and able to distinguish cancer cells from normal cells based on CD44 expression levels and local refractive index changes. A weak interferometric cavity at the fiber tip is responsible for the quasi-random reflection pattern, where refractive index changes induced by cell binding modulate the reflected signal in concentration-dependent manner. Quantitative analysis demonstrated a limit of detection of 48.8 cells/mL and a sensitivity of 1.1 dB/10x for the breast cancer HCC1806 cell line with high level of CD44 expression. The sensor successfully stratified cells from breast and colorectal cancers and demonstrated high specificity by clearly distinguishing cancerous cells from normal kidney epithelial cells. This work contributes to the development of biosensing platforms for whole-cell detection based on phenotypic markers, offering a simple and reproducible approach suitable for integration into microfluidic and future clinical diagnostic systems.